Investor profile

Biogeneration Capital Fund IV C.V.

Biogeneration IV Management B.V. · Multi-Country

EIF

Investment focus

Start with the fit.

BioGeneration Capital Fund IV is an early-stage life sciences fund managed by BioGeneration Ventures, a Naarden-based investor in European biopharma and therapeutic innovation. The fund closed at EUR 140 million and is backed by the European Investment Fund alongside investors including Eli Lilly, Novo Holdings and KfW Capital.

AI Connector · MCP

Bring EUACC into your AI.

Choose your AI and follow the walkthrough. Your free EUACC account connects the two.

Illustrated walkthrough

Add EUACC to Claude

In Claude, open Customize, then Connectors.
Click + Add, then Add custom connector.
Name it EUACC, paste the link and click Continue.
Review the detected authentication settings and click Continue. Choose Sign in now, then Register automatically under OAuth client.
Click Add, then sign in with your free EUACC account and approve access.

Connector URLhttps://www.euacc.ai/api/mcp

Works on every Claude plan, including Free (one custom connector). On Team and Enterprise, an Owner adds it.

On a phone, add it at claude.ai in your browser. It then shows up in the Claude app the next time you sign in.

Once connected, try this

Use EUACC to explore “Biogeneration capital fund iv c v” (https://www.euacc.ai/investors/biogeneration-capital-fund-iv-c-v). Help me assess investor fit and prepare questions using the available fund profiles. Cite the available sources and flag missing or outdated information.

Your side of the introduction

Give investors a profile worth opening.

List your startup →